Palliative Sedation

Mercadante V, Smith DK, Abdalla-Asian R, Andabak-Rogulj A, Brennan MT, et al.

A systematic review of salivary gland hypofunction and/or xerostomia induced by non-surgical cancer therapies: prevention strategies.

Support Care Cancer 2025; 33:87


Tavares T, Almeida J, Gonçalves E, Abelha F.

Dexmedetomidine in palliative care: a versatile new weapon against delirium and pain—systematic review.

J Palliat Med 2024;27:1390-1403


Leslie EA, Byrne J, Mesarwi P, Edmonds KP, Hirst JM, et al.

Descriptive analysis of dexmedetomidine’s utility in a palliative care unit at the end of life.

J Palliat Med 2024;1303-1309


Abrahm J.

Palliative Sedation: Policy and Use of Precedex


Abrahm J.

Patient and Family Concerns About Palliative Sedation


Schuman ZD, Lynch MP, Abrahm JL.

Implementing Institutional Change: An Institutional Case Study of Palliative Sedation

Journal of Palliative Medicine 2005 8(3):666-76


oncology supportive care

About Dr. Abrahm

Janet Abrahm, MD is Professor of Medicine at Harvard Medical School. She is among the founders of Palliative Care in the United States and the author of four comprehensive books on supportive and palliative care for patients with cancer. Dr. Abrahm is a former practicing oncologist who created the Palliative Care Service at Dana-Farber Cancer Institute over 20 years’ ago. She is an award-winning clinician and educator and continues to practice palliative care at Dana Farber.

Learn More

oncology supportive care

Dr. Abrahm's Book

Dr. Abrahm is the author of four comprehensive editions 
on supportive and palliative care for patients with cancer, the first published in 2000 and the latest in 2022.

Her extensive work offers oncologists and other oncology and palliative care clinicians a place to turn to find the most up-to-date evidence-based practices, resources, and practical advice on how to care for patients across the full range of issues they will experience during their illness.

Learn More